P/E at 59.53 vs Industry's 57.73: What the Data Shows for Apollo Hospitals Enterprise Ltd.

1 hour ago

Share Via

A price-to-earnings ratio of 59.53 against an industry average of 57.73 represents a modest premium for Apollo Hospitals Enterprise Ltd.. Previously rated Hold by MarketsMojo, the company’s rating was reassessed on 11 May 2026. While the one-year return of 15.83% comfortably outpaces the Sensex’s decline of 9.15%, the recent three-month performance shows a more subdued 2.47% gain, signalling a shift in momentum that warrants closer examination.

Valuation Picture: Premium Reflects Confidence Amid Sector Dynamics

The current P/E of 59.53 for Apollo Hospitals Enterprise Ltd. is slightly above the hospital industry’s average P/E of 57.73. This premium, while not extreme, suggests that investors are willing to pay a higher multiple for the company’s earnings relative to its peers. Such a valuation often reflects expectations of superior growth or operational resilience. However, the premium is modest enough to raise questions about whether the market’s optimism is fully justified given recent price action — previously rated Hold, what is Apollo Hospitals’ current rating? The valuation premium also aligns with the company’s large-cap status and its dominant position within the hospital sector, which has seen mixed results across its constituents.

Performance Across Timeframes: Divergent Momentum Signals

Examining Apollo Hospitals Enterprise Ltd.’s returns reveals a nuanced picture. Over the past year, the stock has delivered a robust 15.83% gain, significantly outperforming the Sensex’s 9.15% loss. This outperformance extends to longer horizons, with three-year returns at 60.75%, five-year returns at 143.97%, and an impressive ten-year return of 469.81%, all well above the Sensex’s respective 18.19%, 42.58%, and 175.41% gains. Such long-term strength underscores the company’s sustained growth trajectory and market leadership.

However, the short-term momentum is less encouraging. The stock has declined by 1.41% today, underperforming the Sensex’s 0.46% fall, and has lost 3.32% over the past week versus the Sensex’s 2.74% drop. The one-month return of 4.53% is positive but contrasts with the Sensex’s 3.88% decline, while the three-month gain of 2.47% lags behind the more significant one-year outperformance. This divergence suggests that recent market pressures or sector-specific factors may be tempering investor enthusiasm — is this a temporary setback or a sign of deeper challenges?

Moving Average Configuration: Mixed Signals from Technical Indicators

The technical picture for Apollo Hospitals Enterprise Ltd. is somewhat conflicted. The stock currently trades above its 50-day, 100-day, and 200-day moving averages, indicating a longer-term uptrend remains intact. However, it is below its 5-day and 20-day moving averages, reflecting recent short-term weakness. This configuration often signals a pause or consolidation phase within a broader upward trend. The stock’s three-day consecutive decline, resulting in a 4.86% loss, further emphasises this short-term pressure. The opening gap down of 2.78% today and intraday low at Rs 7,874.3 reinforce the notion of near-term volatility — is this a genuine recovery or a relief rally that will fade at the 50 DMA?

Sector Context: Hospital Industry Shows Mixed Performance

The hospital sector, within which Apollo Hospitals Enterprise Ltd. operates, has experienced a varied performance landscape. While some companies have reported positive results, others have remained flat or declined, reflecting the sector’s sensitivity to regulatory changes, healthcare demand fluctuations, and cost pressures. The sector’s average P/E of 57.73 suggests moderate valuation levels, with Apollo Hospitals positioned slightly above this benchmark. This premium may be justified by the company’s scale, brand strength, and diversified healthcare services, but it also means that any sector-wide headwinds could disproportionately affect its stock price.

Rating Context: Previously Rated Hold, Now Reassessed

MarketsMOJO had previously assigned a Hold rating to Apollo Hospitals Enterprise Ltd.. The rating was updated on 11 May 2026, reflecting a reassessment of the company’s fundamentals and market position. While the current rating is not disclosed, the data-driven approach considers valuation, performance, technical indicators, and sector dynamics. This comprehensive analysis helps investors understand the stock’s evolving profile — should investors in Apollo Hospitals hold, buy more, or reconsider?

Conclusion: Data Reflects a Stock Balancing Premium Valuation and Mixed Momentum

The data for Apollo Hospitals Enterprise Ltd. paints a picture of a large-cap stock trading at a modest premium to its sector, supported by strong long-term returns and a solid market position. However, recent short-term underperformance and a mixed moving average configuration suggest caution. The stock’s three-day losing streak and intraday volatility highlight near-term challenges, even as the longer-term trend remains positive. The hospital sector’s uneven performance adds another layer of complexity to the valuation and momentum dynamics. Investors may find value in analysing these factors closely — what is the current rating for Apollo Hospitals Enterprise Ltd.?

Only Rs. 9,999 - Get MojoOne + Stock of the Week for 1 Year Start at 33% Off →

{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)

MOJO SCORE